MoneyWorks4Me

Marksans Pharma - Quaterly Results

30 May 2022 Evaluate
The sales moved up 28.12% to Rs. 1762.78 millions for the March 2022 quarter as compared to Rs. 1375.83 millions during the year-ago period.A slender decline of -9.54% was recorded to Rs. 214.27  millions from Rs. 236.88 millions in the corresponding previous quarter.Operating profit for the quarter ended March 2022 decreased to 345.16 millions as compared to 386.87 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1762.78 1375.83 28.12 6582.89 5995.48 9.80 6582.89 5995.48 9.80
Other Income 76.48 119.08 -35.77 422.51 311.56 35.61 422.51 311.56 35.61
PBIDT 345.16 386.87 -10.78 1559.66 1448.68 7.66 1559.66 1448.68 7.66
Interest 12.78 21.38 -40.22 37.95 53.45 -29.00 37.95 53.45 -29.00
PBDT 332.38 365.49 -9.06 1521.71 1395.23 9.07 1521.71 1395.23 9.07
Depreciation 46.08 41.45 11.17 176.63 151.93 16.26 176.63 151.93 16.26
PBT 286.30 324.04 -11.65 1345.08 1243.30 8.19 1345.08 1243.30 8.19
TAX 72.03 87.16 -17.36 305.20 259.49 17.62 305.20 259.49 17.62
Deferred Tax -11.26 10.58 -206.43 5.04 -22.39 -122.51 5.04 -22.39 -122.51
PAT 214.27 236.88 -9.54 1039.88 983.81 5.70 1039.88 983.81 5.70
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 19.58 28.12 -30.37 23.69 24.16 -1.95 23.69 24.16 -1.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..